Exeltis, USA Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$32.5M
Doctors Paid
26,163
Transactions
99,321
2024 Total
$7.7M
Payment Breakdown by Category
Research$29.1M (89.6%)
Food & Beverage$1.7M (5.3%)
Consulting$1.3M (3.8%)
Travel$50,829 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $29.1M | 4,299 | 89.6% |
| Food and Beverage | $1.7M | 94,408 | 5.3% |
| Consulting Fee | $1.3M | 361 | 3.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $203,576 | 48 | 0.6% |
| Honoraria | $126,303 | 43 | 0.4% |
| Travel and Lodging | $50,829 | 158 | 0.2% |
| Space rental or facility fees (teaching hospital only) | $8,400 | 4 | 0.0% |
Payments by Type
Research
$29.1M
4,299 transactions
General
$3.4M
95,022 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women | $15.7M | 0 | 1,509 |
| CF13303 | $3.9M | 0 | 531 |
| LF11401 | $2.9M | 0 | 615 |
| A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles | $2.4M | 0 | 812 |
| A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability ofLPRI-424, 13 Cycles | $2.1M | 2 | 40 |
| Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability of LPRI-424, 13 Cycles | $1.5M | 0 | 623 |
| Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females | $457,388 | 0 | 117 |
| LR-303 | $198,100 | 0 | 52 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Michael Krychman, Md, MD | Gynecology | Costa Mesa, CA | $470,664 | $0 |
| Dr. Rex Mabey, M.d, M.D | Obstetrics & Gynecology | Las Vegas, NV | $155,410 | $0 |
| Dr. Youssef Mouhayar, M.d, M.D | Obstetrics & Gynecology | Miami, FL | $132,634 | $0 |
| Mark Nestor, M.d, M.D | Dermatology | Aventura, FL | $130,875 | $0 |
| Catherine Hansen, Md, MD | Obstetrics & Gynecology | Webster, TX | $122,307 | $0 |
| Arthur Waldbaum, Md, MD | Gynecology | Denver, CO | $106,820 | $0 |
| Thomas Kimble, Md, MD | Obstetrics & Gynecology | Norfolk, VA | $51,320 | $0 |
| Darrell Rigel, Md, MD | Dermatology | New York, NY | $40,000 | $0 |
| Mrs. Jordan Neighbors, D.o, D.O | Obstetrics & Gynecology | Chandler, AZ | $30,964 | $0 |
| Leon Kircik, Md, MD | Dermatology | Lousiville, KY | $28,500 | $0 |
| Dr. Jennifer Elliott, M.d, M.D | Obstetrics & Gynecology | Alpharetta, GA | $27,346 | $0 |
| Dr. Harold Farber, M.d,, M.D, | Dermatology | Philadelphia, PA | $23,703 | $0 |
| Jessica Shepherd, M.d, M.D | Gynecology | Dallas, TX | $22,900 | $0 |
| Ingrid Paredes, Md, MD | Obstetrics & Gynecology | Miami, FL | $17,673 | $0 |
| Dr. John Thoppil, Md, MD | Obstetrics & Gynecology | Austin, TX | $14,350 | $0 |
| Lisa Rarick, Md, MD | Obstetrics & Gynecology | Chesapeake Beach, MD | $13,923 | $0 |
| Sanjay Chabra, D.o, D.O | Rheumatology | El Paso, TX | $13,366 | $0 |
| Jasvinder Singh | Internal Medicine | Houston, TX | $13,325 | $0 |
| Dr. Ana Eduardo, M.d, M.D | Obstetrics & Gynecology | Austin, TX | $12,394 | $0 |
| Dr. Marc Brenner, D.p.m, D.P.M | Podiatrist | Glendale, NY | $12,000 | $0 |
| Quan Nguyen, Md, MD | Ophthalmology | Stanford, CA | $11,108 | $0 |
| Dr. Scott Eder, Md, MD | Gynecology | Princeton, NJ | $9,731 | $0 |
| Peter Mcallister, M.d, M.D | Neurology | Fairfield, CT | $9,722 | $0 |
| Dr. Julianne Adams Birt, M.d, M.D | Obstetrics & Gynecology | Conyers, GA | $9,309 | $0 |
| Sonia Rebeles, Md, MD | Obstetrics & Gynecology | Fresno, CA | $9,118 | $0 |
Ad
Top Products
- LPRI-CF113 $11.6M
- SLYND $8.8M
Associated Products (13)
- LPRI-CF113 $11.6M
- SLYND $8.8M
- LPRI-424 $6.8M
- Vitafol Ultra $298,331
- Ecoza $276,728
- Slynd $93,623
- Vitafol Prenatal $72,462
- Neosalus $20,482
- Nuvessa $20,392
- Recedo $20,136
- TYBLUME $16,262
- TWIRLA $14,079
- Ecoza Foam $12,839
Payment Categories
- Food & Beverage $1.7M
- Consulting $1.3M
- Travel & Lodging $50,829
- Research $29.1M
About Exeltis, USA Inc.
Exeltis, USA Inc. has made $32.5M in payments to 26,163 healthcare providers, recorded across 99,321 transactions in the CMS Open Payments database. In 2024, the company paid $7.7M. The top product by payment volume is LPRI-CF113 ($11.6M).
Payments were distributed across 180 medical specialties. The top specialty by payment amount is Obstetrics & Gynecology ($1.6M to 10,711 doctors).
Payment categories include: Food & Beverage ($1.7M), Consulting ($1.3M), Research ($29.1M), Travel & Lodging ($50,829).
Exeltis, USA Inc. is associated with 13 products in the CMS Open Payments database, including LPRI-CF113, SLYND, and LPRI-424.